The biotechnology company Amgen has announced its incorporation as a member of the Spanish Association of Biosimilar Medicines, BioSim. This fact reinforces the company's commitment to the sustainability of the health system, promoting early and equitable access to safe and effective biological therapies for the treatment of people living with serious chronic diseases.